Exagen Inc. corporate insiders have only been selling lately: two insiders reduced their stakes by about $628,000 of stock over 12 months, with no open-market purchases.
Keep in mind most insider selling is routine — stock-based pay has to be converted to cash at some point.
Zooming out by quarter: Last full quarter: net selling by insiders. Insiders bought in 0 of the last 7 full quarters. Big money check: 57 institutions held XGN as of Q2 2026, and more funds sold than bought.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | Black Jeffrey G. | CFO | Sell | 20,614 | $7.22 | $149K | SEC |
| Mar 4, 2026 | ABALLI JOHN | CEO | Sell | 15,698 | $3.62 | $57K | SEC |
| Feb 25, 2026 | ABALLI JOHN | CEO | Sell | 11,430 | $3.61 | $41K | SEC |
| Feb 25, 2026 | Black Jeffrey G. | CFO | Sell | 1,584 | $3.61 | $6K | SEC |
| Oct 20, 2025 | ABALLI JOHN | CEO | Sell | 31,787 | $11.82 | $376K | SEC |
| Sep 4, 2025 | Black Jeffrey G. | CFO | Sell | 20,466 | $9.79 | $200K | SEC |
| Mar 27, 2025 | NMSIC Co-Investment Fund, L.P. | 10% Owner | Sell | 350,000 | $3.30 | $1.2M | SEC |
| Nov 27, 2024 | Sun Mountain Capital Partners LLC | 10% Owner | Sell | 200,000 | $3.30 | $660K | SEC |
| Nov 19, 2024 | Black Jeffrey G. | CFO | Buy | 22,298 | $2.98 | $66K | SEC |
| Nov 18, 2024 | ABALLI JOHN | CEO | Buy | 24,305 | $2.81 | $68K | SEC |
| May 16, 2024 | ABALLI JOHN | CEO | Buy | 40,401 | $1.92 | $78K | SEC |
| Mar 6, 2024 | Adawi Kamal | CFO | Sell | 3,487 | $1.91 | $7K | SEC |
| Mar 6, 2024 | Adawi Kamal | CFO | Sell | 9,297 | $1.91 | $18K | SEC |
| Feb 8, 2024 | Adawi Kamal | CFO | Sell | 6,738 | $1.95 | $13K | SEC |
| Oct 18, 2023 | ABALLI JOHN | CEO | Sell | 33,819 | $1.75 | $59K | SEC |
In the last 12 months Exagen Inc. insiders made open-market purchases worth about $0 and sales worth about $628,000. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in XGN was filed on 2026-09-02.
57 investment managers reported holding XGN in SEC Form 13F filings for Q2 2026.
No congressional trades in XGN were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).